Biotech, Case Studies, Research Organisations & Companies, Strategy & Consulting
ERS Genomics THE CHALLENGE ERS Genomics manages and licenses the IP for CRISPR/Cas9 gene editing technology. While the technology itself is well known, far fewer people in the life sciences space are aware that they need to secure the appropriate licences to use it....
Case Studies, Charities & Societies, Content, Strategy & Consulting
THE SAN FRANCISCO DECLARATION ON RESEARCH ASSESSMENT (dora) THE CHALLENGE The San Francisco Declaration on Research Assessment (DORA) was developing a new online tool to help academic institutions assess research in a fairer way. They wanted to reach a broad, global...
Case Studies, Charities & Societies, Research Organisations & Companies, Strategy & Consulting
Research on research institute THE CHALLENGE The Research on Research Institute (RoRI) generates data and analysis to improve how research is funded, practised, evaluated and communicated in order to realise its full potential. First Create The Media acted as RoRI’s...
Case Studies, Charities & Societies, Research Organisations & Companies, Strategy & Consulting
Research on research institute THE CHALLENGE The Research on Research Institute (RoRI) generates data and analysis to improve how research is funded, practised, evaluated and communicated in order to realise its full potential. As they came to the end of their pilot...
Charities & Societies, Content, Founders, Research Organisations & Companies, Startups, Strategy & Consulting
By Kat Arney, Creative Director at First Create The Media. Want more tips for telling the stories about your science? Sign up for our newsletter. We hear a lot about the importance of telling stories, whether it’s about scientific research or more broadly about an...
Founders, Research Organisations & Companies, Startups, Strategy & Consulting, Workshops & Training
‘Boring Comms Waste Lives’ is my new mantra. Hours of human life are being wasted sitting through boring presentations or listlessly turning the pages of indigestible reports. More importantly, if your biomedical research, product or company could save lives but...
